398 related articles for article (PubMed ID: 16736756)
1. Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent.
Zhu D; White RD; Hardy PA; Weerapreeyakul N; Sutthanut K; Jay M
J Nanosci Nanotechnol; 2006 Apr; 6(4):996-1003. PubMed ID: 16736756
[TBL] [Abstract][Full Text] [Related]
2. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
Zhu D; Lu X; Hardy PA; Leggas M; Jay M
Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
4. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
[TBL] [Abstract][Full Text] [Related]
6. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and complexation properties of DTPA-N,N''-bis[bis(n-butyl)]-N'-methyl-tris(amide). Kinetic stability and water exchange of its Gd3+ complex.
Jaszberényi Z; Tóth E; Kálai T; Király R; Burai L; Brücher E; Merbach AE; Hideg K
Dalton Trans; 2005 Feb; (4):694-701. PubMed ID: 15702179
[TBL] [Abstract][Full Text] [Related]
8. Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetallation assessment.
Laurent S; Elst LV; Copoix F; Muller RN
Invest Radiol; 2001 Feb; 36(2):115-22. PubMed ID: 11224760
[TBL] [Abstract][Full Text] [Related]
9. A novel one-step synthesis of Gd3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent.
Shao YZ; Liu LZ; Song SQ; Cao RH; Liu H; Cui CY; Li X; Bie MJ; Li L
Contrast Media Mol Imaging; 2011; 6(2):110-8. PubMed ID: 21504064
[TBL] [Abstract][Full Text] [Related]
10. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
[TBL] [Abstract][Full Text] [Related]
11. Nanosized
Arosio P; Cicolari D; Manfredi A; Orsini F; Lascialfari A; Ranucci E; Ferruti P; Maggioni D
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011405
[TBL] [Abstract][Full Text] [Related]
12. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
[TBL] [Abstract][Full Text] [Related]
14. Multi-functional chitosan nanoparticles encapsulating quantum dots and Gd-DTPA as imaging probes for bio-applications.
Tan WB; Zhang Y
J Nanosci Nanotechnol; 2007 Jul; 7(7):2389-93. PubMed ID: 17663257
[TBL] [Abstract][Full Text] [Related]
15. DNA surface modified gadolinium phosphate nanoparticles as MRI contrast agents.
Dumont MF; Baligand C; Li Y; Knowles ES; Meisel MW; Walter GA; Talham DR
Bioconjug Chem; 2012 May; 23(5):951-7. PubMed ID: 22462809
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Microenvironment Relaxivity-Changeable Gd-Loaded Poly(L-lysine)/Carboxymethyl Chitosan Nanoparticles as Cancer-Recognizable Magnetic Resonance Imaging Contrast Agents.
Jiang D; Zhang X; Yu D; Xiao Y; Wang T; Su Z; Liu Y; Zhang N
J Biomed Nanotechnol; 2017 Mar; 13(3):243-54. PubMed ID: 29381026
[TBL] [Abstract][Full Text] [Related]
17. Relaxivity of liposomal paramagnetic MRI contrast agents.
Strijkers GJ; Mulder WJ; van Heeswijk RB; Frederik PM; Bomans P; Magusin PC; Nicolay K
MAGMA; 2005 Sep; 18(4):186-92. PubMed ID: 16155762
[TBL] [Abstract][Full Text] [Related]
18. Novel Gd nanoparticles enhance vascular contrast for high-resolution magnetic resonance imaging.
Bui T; Stevenson J; Hoekman J; Zhang S; Maravilla K; Ho RJ
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927340
[TBL] [Abstract][Full Text] [Related]
19. Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imaging and emission spectroscopy.
Haar PJ; Broaddus WC; Chen ZJ; Fatouros PP; Gillies GT; Corwin FD
Phys Med Biol; 2010 Jun; 55(12):3451-65. PubMed ID: 20508321
[TBL] [Abstract][Full Text] [Related]
20. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity.
Chen KJ; Wolahan SM; Wang H; Hsu CH; Chang HW; Durazo A; Hwang LP; Garcia MA; Jiang ZK; Wu L; Lin YY; Tseng HR
Biomaterials; 2011 Mar; 32(8):2160-5. PubMed ID: 21167594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
